Central core disease: new findings in an old disease.
Central core disease: new findings in an old disease.
复制标题
中央核心疾病:老病的新发现。
DOI:
--
复制
发表时间:
2003
期刊:
影响因子:
--
通讯作者:
C. Sewry
中科院分区:
文献类型:
--
作者:
Francesco Muntoni;C. Sewry
Central core disease (CCD) is a clearly defined clinical condition with striking pathological changes that facilitate the diagnosis. The condition was first reported in 1956 by Shy and Magee (1956) who described a dominant family in which muscle fibres had a central area devoid of oxidative enzyme activity. They named the disorder central core disease, after this histopathological feature. Since then many similar cases have been identified, confirming that this is a distinct disorder.
Relatively little happened between 1956 and 1990, when linkage to chromosome 19q.13 was established, followed in 1993 by the identification of mutations in the ryanodine receptor gene ( RYR1 ). Mutations in the same gene also occur in patients with malignant hyperthermia susceptibility (MHS) (McCarthy et al ., 2000), some of whom show core lesions, although they may have no muscle weakness.
The large size of the RYR1 gene (106 exons) has made it difficult to study large populations of patients and establish a genotype–phenotype correlation. However, significant pathological and molecular advances have recently been made. We now know that cases with eccentric or peripheral cores, and/or multiple minicores, or cases showing only uniformity of type 1 fibres with an absence of cores, or cases with only mild unevenness of oxidative enzyme staining, or cases with marked muscle replacement by fatty tissue in association …